23andMe Succumbs to Layoffs, Cutting 40% of Its Workforce
HR Digest
NOVEMBER 12, 2024
23andMe is in pursuit of a strategic shift away from its research business wing and the development of new therapies, and will instead focus its attention on genetic testing and selling its existing products. Genetic testing company 23andMe has announced layoffs at its organization, with plans to bring down its workforce by 40%.
Let's personalize your content